231 related articles for article (PubMed ID: 24292775)
41. Long-term follow-up data from the Shunt Design Trial.
Kestle J; Drake J; Milner R; Sainte-Rose C; Cinalli G; Boop F; Piatt J; Haines S; Schiff S; Cochrane D; Steinbok P; MacNeil N
Pediatr Neurosurg; 2000 Nov; 33(5):230-236. PubMed ID: 11155058
[TBL] [Abstract][Full Text] [Related]
42. Clinical experience with the use of a shunt with an adjustable valve in children with hydrocephalus.
Zemack G; Bellner J; Siesjö P; Strömblad LG; Romner B
J Neurosurg; 2003 Mar; 98(3):471-6. PubMed ID: 12650416
[TBL] [Abstract][Full Text] [Related]
43. A multicenter prospective cohort study of the Strata valve for the management of hydrocephalus in pediatric patients.
Kestle JR; Walker ML;
J Neurosurg; 2005 Mar; 102(2 Suppl):141-5. PubMed ID: 16156221
[TBL] [Abstract][Full Text] [Related]
44. On the method of a randomised comparison of programmable valves with and without gravitational units: the SVASONA study.
Lemcke J; Meier U; Müller C; Fritsch M; Kiefer M; Eymann R; Kehler U; Langer N; Schuhmann MU; Speil A; Weber F; Remenez V; Rohde V; Ludwig HC; Stengel D
Acta Neurochir Suppl; 2012; 114():243-6. PubMed ID: 22327702
[TBL] [Abstract][Full Text] [Related]
45. Female gender predisposes for cerebrospinal fluid overdrainage in ventriculoperitoneal shunting.
Diesner N; Freimann F; Clajus C; Kallenberg K; Rohde V; Stockhammer F
Acta Neurochir (Wien); 2016 Jul; 158(7):1273-8. PubMed ID: 27177735
[TBL] [Abstract][Full Text] [Related]
46. Gravity assisted vs. medium pressure valves for communicating hydrocephalus show similar valve-revision rates.
Schatlo B; Hamed M; Grote A; Schramm J; Neuloh G
Acta Neurochir (Wien); 2013 Oct; 155(10):1987-91. PubMed ID: 23989996
[TBL] [Abstract][Full Text] [Related]
47. Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus.
Reddy GK; Bollam P; Caldito G
World Neurosurg; 2014 Feb; 81(2):404-10. PubMed ID: 23380280
[TBL] [Abstract][Full Text] [Related]
48. Syndrome of overdrainage associated with disconnection of a ventriculoperitoneal shunt.
Rosenthal G; Pomeranz S; Spektor S; Yacoub M; Israel ZH
Pediatr Neurosurg; 1999 Sep; 31(3):124-6. PubMed ID: 10708352
[TBL] [Abstract][Full Text] [Related]
49. Ventriculoperitoneal shunt of continuous flow vs valvular shunt for treatment of hydrocephalus in adults.
Sotelo J; Arriada N; López MA
Surg Neurol; 2005 Mar; 63(3):197-203; discussion 203. PubMed ID: 15734497
[TBL] [Abstract][Full Text] [Related]
50. Postshunt insertion CSF leaks in infants treated by an adjustable valve opening pressure reduction.
Rohde V; Weinzierl M; Mayfrank L; Gilsbach JM
Childs Nerv Syst; 2002 Dec; 18(12):702-4. PubMed ID: 12483354
[TBL] [Abstract][Full Text] [Related]
51. The gravity-assisted Paedi-Gav valve in the treatment of pediatric hydrocephalus.
Meling TR; Egge A; Due-Tønnessen B
Pediatr Neurosurg; 2005; 41(1):8-14. PubMed ID: 15886507
[TBL] [Abstract][Full Text] [Related]
52. Choice of valve type and poor ventricular catheter placement: Modifiable factors associated with ventriculoperitoneal shunt failure.
Jeremiah KJ; Cherry CL; Wan KR; Toy JA; Wolfe R; Danks RA
J Clin Neurosci; 2016 May; 27():95-8. PubMed ID: 26758704
[TBL] [Abstract][Full Text] [Related]
53. Overdrainage shunt complications in idiopathic normal-pressure hydrocephalus and lumbar puncture opening pressure.
Khan QU; Wharen RE; Grewal SS; Thomas CS; Deen HG; Reimer R; Van Gerpen JA; Crook JE; Graff-Radford NR
J Neurosurg; 2013 Dec; 119(6):1498-502. PubMed ID: 23930853
[TBL] [Abstract][Full Text] [Related]
54. Minimizing overdrainage with flow-regulated valves - Initial results of a prospective study on idiopathic normal pressure hydrocephalus.
Wetzel C; Goertz L; Schulte AP; Goldbrunner R; Krischek B
Clin Neurol Neurosurg; 2018 Oct; 173():31-37. PubMed ID: 30071502
[TBL] [Abstract][Full Text] [Related]
55. Adjustable pressure valves for chronic hydrocephalus following subarachnoid hemorrhage: Is it worthwhile?
Darkwah Oppong M; Droste L; Pierscianek D; Wrede KH; Rauschenbach L; Dammann P; Herten A; Forsting M; Sure U; Jabbarli R
Clin Neurol Neurosurg; 2020 Nov; 198():106133. PubMed ID: 32791438
[TBL] [Abstract][Full Text] [Related]
56. Retrospective single-center historical comparative study between proGAV and proGAV2.0 for surgical revision and implant duration.
Brunner E; Schaumann A; Pennacchietti V; Schulz M; Thomale UW
Childs Nerv Syst; 2022 Jun; 38(6):1155-1163. PubMed ID: 35353205
[TBL] [Abstract][Full Text] [Related]
57. Randomized trial of cerebrospinal fluid shunt valve design in pediatric hydrocephalus.
Drake JM; Kestle JR; Milner R; Cinalli G; Boop F; Piatt J; Haines S; Schiff SJ; Cochrane DD; Steinbok P; MacNeil N
Neurosurgery; 1998 Aug; 43(2):294-303; discussion 303-5. PubMed ID: 9696082
[TBL] [Abstract][Full Text] [Related]
58. Effect of antisiphon devices on ventriculoperitoneal shunt drainage dynamics in growing children.
Tachatos N; Fernandes Dias S; Jehli E; Lübben D; Schuhmann MU; Schmid Daners M
J Neurosurg Pediatr; 2023 Jul; 32(1):50-59. PubMed ID: 37119102
[TBL] [Abstract][Full Text] [Related]
59. Using individualized opening pressure to determine the optimal setting of an adjustable proGAV shunt in treatment of hydrocephalus in infants.
Xinxing L; Hongyu D; Yunhui L
Childs Nerv Syst; 2015 Aug; 31(8):1267-71. PubMed ID: 26143276
[TBL] [Abstract][Full Text] [Related]
60. Clinical performance of fixed-pressure Sphera Duo® hydrocephalus shunt.
Pinto FCG; Oliveira MF; Castro JPS; Morais JVR; Pinto FMG; Teixeira MJ
Arq Neuropsiquiatr; 2020 Jan; 78(1):9-12. PubMed ID: 32074184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
